Inovio Pharmaceuticals (INO) Earnings Date & Reports

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

INO is expected to report earnings to rise 1,266.67% to -123 cents per share on March 13

Inovio Pharmaceuticals INO Stock Earnings Reports

Q4'23

Est.

$-1.23

Q3'23

Beat

by $0.04

Q2'23

Beat

by $0.02

Q1'23

Beat

by $0.31

Q4'22

Missed

by $0.05

The last earnings report on November 09 showed earnings per share of -9 cents, beating the estimate of -12 cents. With 459.96K shares outstanding, the current market capitalization sits at 70.39M.

View a ticker or compare two or three

Compare

INO